Results 191 to 200 of about 89,048 (269)

Extranodal natural killer/T‐cell lymphoma: From fatal to curable

open access: yesCA: A Cancer Journal for Clinicians, Volume 76, Issue 4, July/August 2026.
Abstract Extranodal natural killer (NK)/T‐cell lymphoma (ENKTCL) is one of the most aggressive non‐Hodgkin lymphomas characterized by NK‐cell or T‐cell origins, a geographic prevalence in Asian and South American populations, and Epstein–Barr virus (EBV) infection.
Jie Xiong   +12 more
wiley   +1 more source

A yeast-based platform for etoposide production via yatein bioconversion. [PDF]

open access: yesMetab Eng Commun
Gautron N   +16 more
europepmc   +1 more source

Extracorporeal Cytokine Hemadsorption for the Treatment of Severe Steroid Refractory Cytokine Release Syndrome Secondary to T‐Cell Immunotherapy for B‐Cell Malignancies: A Case Series

open access: yes
Hematological Oncology, Volume 44, Issue 4, July 2026.
Gianluca Cavallaro   +12 more
wiley   +1 more source

Molecular–clinical characteristics and treatment outcomes in 163 metastatic colorectal neuroendocrine carcinomas with a comparison to colorectal adenocarcinomas

open access: yesInternational Journal of Cancer, Volume 158, Issue 12, Page 3217-3231, 15 June 2026.
What's new? Colorectal neuroendocrine carcinoma (CR‐NEC) is a rare digestive neuroendocrine neoplasm that frequently exhibits an adenocarcinoma component. Nonetheless, the underlying biology of CR‐NEC remains poorly understood. This study examined molecular and clinical features and palliative chemotherapy outcomes of metastatic CR‐NEC, with comparison
Siren Morken   +20 more
wiley   +1 more source

A randomized comparison of etoposide and cyclophosphamide for stem cell mobilization in newly diagnosed multiple myeloma. [PDF]

open access: yesSci Rep
Sun Y   +13 more
europepmc   +1 more source

Synergistic Antitumor Effects of Etoposide and Curcumin in Ovarian Cancer Cells. [PDF]

open access: yesBiomedicines
Çavuş Y   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy